Ron Kocak - 09 Feb 2024 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
VP, Controller and PAO
Signature
/s/ Ronald Kocak
Issuer symbol
RNXT
Transactions as of
09 Feb 2024
Net transactions value
$0
Form type
4
Filing time
12 Feb 2024, 19:46:10 UTC
Next filing
10 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Options Award +15,000 15,000 09 Feb 2024 Common Stock 15,000 $1.59 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 10-year incentive stock options to purchase 15,000 shares of the Company's common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan. These options vest over four years at a rate of 1/48 per month, beginning vesting on the date.